IncontiLase®
Stress Urinary Incontinence Laser Treatment
P3SnLZUeWC8
IncontiLase® is a patent-pending, non-invasive Er:YAG laser therapy for the treatment of mild and moderate stress urinary incontinence, based on non-ablative photothermal stimulation of collagen neogenesis, shrinking and tightening of vaginal mucosa tissue and collagen-rich endopelvic fascia, and subsequently greater support to the bladder.
The indications for IncontiLase therapy are mild and moderate stress- and mixed-urinary incontinence (SUI). Preliminary clinical studies show that it is an efficient, easy-to-perform and safe procedure.
Abstracts of published scientific studies examining the effectiveness and safety of Fotona SMOOTH® laser therapy in gynecology can be found in the following Compendium of Clinical Studies.
For more information please visit the Fotona SMOOTH® website which is tailored for both patients and doctors.
How does IncontiLase® work?
- Fotona’s 2940 nm Er:YAG non-ablative laser with proprietary “Smooth-mode” technology thermally affects the vaginal tissue, stimulating collagen remodeling and the synthesis of new collagen fibers in the region of the vestibule and urethral orifice, as well as in the area along the anterior vaginal wall.
- The final result of collagen neogenesis is the shrinking and tightening of vaginal mucosa tissue and collagen-rich endopelvic fascia and subsequently greater support to the bladder and the return of normal continence function.
Unique advantages of IncontiLase® for your patients
A major advantage of IncontiLase is that the procedure is incisionless and virtually painless, with no ablation, cutting, bleeding, or sutures. Recovery is extremely quick without need for the use of analgesics or antibiotics.
Usually two sessions are recommended to alleviate mild or even moderate stress urinary incontinence. No special pre-op preparation or post-op precautions are necessary. Patients can immediately return to their normal everyday activities.
Studies confirm that IncontiLase is an effective, safe and comfortable treatment option for symptom relief in patients with mild and moderate SUI.
Exceptional clinical results
Scientific results from clinical studies (see the Library tab) show excellent improvement for mild and moderate stress urinary incontinence.
- Almost 70% of patients are dry after 120 days.
- 120 days after IncontiLase treatment 94% of patients reported improvement and 68% of all patients claimed to be free of SUI symptoms.
- Improvement of SUI in all measured parameters.
- No adverse events noted in any of the studies.
Getting started with IncontiLase®
Training in IncontiLase will be provided through the Laser and Health Academy* as a stand-alone training workshop under the guidance of experts in medical laser technology. The extensive workshop, where participants engage in live demonstrations and gain an in-depth understanding of laser physics and laser-tissue interaction, will provide the needed insights into the fundamentals of the IncontiLase treatment and other procedures that can be performed with this special Er:YAG laser system.
IncontiLase® and other clinical gynecology treatments can be performed with the following Fotona laser systems:
- The TimeWalker® IntimaLaser™ is a unique new laser platform dedicated to gynecological treatments. With two complementary laser wavelengths (Er:YAG and Nd:YAG) exceptional versatility is achieved – from gentle ablative to non-ablative thermal treatments. Safe, tested and proven solutions are available for a wide range of gynecological applications, from the simple removal of lesions to bloodless high-precision cutting.
- The FotonaSmooth SP multi-application laser system from Fotona provides a single, uniquely capable gynecology solution that combines the power of the industry's highest performance Er:YAG, Nd:YAG and QCW* Nd:YAG lasers, ideal for treating all gynecological applications plus a wide range of other treatments in aesthetics, dermatology, and surgery.
- The FotonaSmooth XS Er:YAG laser offers the power and precision to perform an impressive range of non-contact, non-invasive gynecological procedures with greater patient comfort, reduced downtime and quicker healing. In addition to gynecology treatments, the FotonaSmooth XS is also a powerful skin rejuvenation solution, with functions ranging from superficial to deep peels, from non-ablative to fully ablative and from full-field to fractional resurfacing.
Superior Performance
The FotonaSmooth XS and SP systems are both equipped with a high performance VSP Er:YAG laser that ablates tissue efficiently and can be accurately tuned to varying “cold” ablation and non-ablative thermal ratios. Full customizability allows you to precisely attain the clinical outcomes your patients require.
The complementary Nd:YAG laser on FotonaSmooth SP lasers penetrates deeply to create thermal effects without damaging the skin surface. Compared to conventional Nd:YAG technologies, Fotona’s proprietary VSP (Variable Square Pulse) technology creates virtually instantaneous temperature increases that are limited to the targeted structures only. No unnecessary energy is deposited into the tissue.
Handpieces & Accessories
Fotona's specially designed, innovative handpiece technology allows safe, precisely controlled and effective delivery of laser pulses to the treatment area. More information about handpieces and other accessories is available on the above product pages.
Clinical Results
Clinical Results
Stress Urinary Incontinence Treatment
Courtesy of: Urska B. Ogrinc, MD & Sabina Sencar, MD & Helena Lenasi,
MD
Laser source: Non-Ablative Er:YAG
What is VSP?
VSP (Variable Square Pulse) technology is a patented solution for generating square laser pulses for more controlled energy absorption. Pulse durations can be adjusted from 50 us up to 1500 us, depending on the practitioner’s needs. VSP pulse technology minimizes unnecessary laser energy absorption into body tissues and helps to ensure ultimate performance and patient comfort during laser treatments.
Scientific & Clinical Research
Scientific & Clinical Research Library:
Vaginal erbium laser treatment for stress urinary incontinence: A multicenter randomized sham-controlled clinical trial - Read Full Text.
O'Reilly BA, Viereck V, Phillips C, Toozs-Hobson P, Kuhn A, Athanasiou S, Lukanović A, Palmer B, Dahly D, Daykan Y, Cardozo L. Int J Gynaecol Obstet. 2023 Nov 5. doi: 10.1002/ijgo.15222
Efficacy and safety of intraurethral Erbium:YAG laser treatment in women with stress urinary incontinence following failed intravaginal laser therapy: a retrospective study - Read Full Text.
Tseng YL, Su CF. Lasers Med Sci. 2023 Sep 9;38(1):207. doi: 10.1007/s10103-023-03872-5
Comparison of Er:YAG and CO(2) laser therapy for women with stress urinary incontinence - Read Full Text.
Li, P.-C. & Ding, D.-C. Lasers Surg Med. 2023; 1– 9. https://doi.org/10.1002/lsm.23694
Long-Term Improvement in Urinary Incontinence in an Elite Female Athlete Through the Laser Treatment: A Case Report - Read Full Text.
Okui, N., Ikegami, T., Mikic, A.N., Okui, M. & Gaspar, A., Cureus. 2023 Mar 27;15(3):e36730. doi: 10.7759/cureus.36730.
SUI in postmenopausal women: advantages of an intraurethral + intravaginal Er:YAG laser - Read Full Text.
Erel, C.T., Gambacciani, M., Ozcivit Erkan, I.B., Gokmen Inan, N., Hamzaoglu Canbolat, K. & Fidecicchi, T., 2023. Climacteric : the journal of the International Menopause Society, pp.1–7
Erbium Laser Thermo-Therapy for Female Stress Urinary Incontinence – 18 months Follow-up - Read Full Text.
Mikić Novakov, A., Bingold, B. L., Korošec, B., & Vi, Z. (2022). LA&HA - Journal of the Laser and Health Academy, 201–5
First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study - Read Full Text.
Fistonić N, Fistonić I, Lukanovič A, Guštek ŠF, Turina IS, Franić D. Climacteric. 2015 Oct;18 Suppl 1:37-42.
Novel minimally invasive laser treatment of urinary incontinence in women - Read Full Text.
Ogrinc UB, Senčar S, Lenasi H. Lasers Surg Med., 2015: 47(9): 689-97.
Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function - Read Full Text.
Tien YV, et al. Tien YW, Hsiao SM, Lee CN, Lin HH. International Urogynecology Journal, 2017, Mar 1;28(3):469-76.
Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women – a pilot study - Read Full Text.
Fistonic N, Fistonic I, Findri Gustek S, Sorta Bilajac Turina I, Franic D, Vizintin Z, Kazic M, Hreljac I, Perhavec T, Lukac M. Lasers in Medical Science, 2016: vol. 31 (4) pp 635-43.
Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency) - Read Full Text.
Gaspar A, Brandi H. Lasers in medical science. 2017 Apr 1;32(3): 685-91.
Baseline ICIQ-UI score, body mass index, age, average birth weight, and perineometry duration as promising predictors of the short-term efficacy of Er:YAG laser treatment in stress urinary incontinent women: A prospective cohort study - Read Full Text.
Fistonić I, Fistonić N. Lasers Surg Med. 2018 Jan 23. doi: 10.1002/lsm.22789
Non-ablative Er:YAG Laser Therapy Effect on Stress Urinary Incontinence Related to Quality of Life and Sexual Function: A Randomized Controlled Trial - Read Full Text.
Blaganje, M., Šćepanović, D., Žgur, L., Verdenik, I., Pajk, F., Lukanović, A. European Journal of Obstetrics & Gynecology and Reproductive Biology 224 (2018):153–158
Comparison between erbium ‑ doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence - Read Full Text.
Okui N. World J Urol. 2019 May;37(5):885-889. doi: 10.1007/s00345-018-2445-x
The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress urine incontinence and sexual dysfunction - Read Full Text.
Lin HY, Tsai HW, Tsui KH, An YF, Lo CC, Lin ZH, Liou WS, Wang PH. Taiwan J Obstet Gynecol. 2018 Dec;57(6):825-829. doi: 10.1016/j.tjog.2018.10.010
Predictive factors for the efficacy of Er:YAG laser treatment of urinary incontinence - Read Full Text.
Erel CT, Inan D, Mut A. Maturitas. 2020 Feb;132:1-6. doi: 10.1016/j.maturitas.2019.11.003
Erbium:YAG laser treatment of female stress urinary incontinence: midterm data - Read Full Text.
Kuszka, A., Gamper, M., Walser, C. et al. Int Urogynecol J 31, 1859–1866 (2020). https://doi.org/10.1007/s00192-019-04148-9
Er:YAG laser treatment of urinary incontinence after failed TOT/TVT procedures - Read Full Text.
Erel, C.T. et al. European journal of obstetrics, gynecology, and reproductive biology (2020), 252, pp.399–403.
Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years - Read Full Text.
Gambacciani M, Cervigni M, Gaspar A, Novakov Mikić A, Gaviria J, Koron N, Vizintin Z. Climacteric. 2020;23(sup1):S28-S32. doi: 10.1080/13697137.2020.1813098
Er:YAG laser in hysterectomized women with stress urinary incontinence: a VELA retrospective cohort, non-inferiority study - Read Full Text.
C. T. Erel, I. Fistonić, M. Gambacciani, Y. Oner & N. Fistonić. Climacteric (2020), 23:sup1, S18-S23
Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis - Read Full Text.
Okui N, Miyazaki H, Takahashi W, Miyauchi T, Ito C, Okui M, Shigemori K, Miyazaki Y, Vizintin Z, Lukac M. Lasers Med Sci. 2022 Feb;37(1):655-663. doi: 10.1007/s10103-021-03317-x
Vaginal erbium laser for treatment of stress urinary incontinence: optimization of treatment regimen for a sustained long-term effect - Read Full Text.
Gaspar A, Koron N, Silva J, Brandi H. Lasers Med Sci. 2022 Jun;37(4):2157-2164. doi: 10.1007/s10103-021-03474-z
Changes in sexual function and vaginal topography using transperineal ultrasound after vaginal laser treatment for women with stress urinary incontinence - Read Full Text.
Long CY, Wu PC, Chen HS, Lin KL, Loo Z, Liu Y, Wu CH. Sci Rep. 2022 Mar 2;12(1):3435. doi: 10.1038/s41598-022-06601-0
Study of Proliferative Activity of Vaginal Epithelium in Women with Stress Urinary Incontinence Treated by Er:YAG Laser - Read Full Text.
Lapii GA, Yakovleva AY, Neimark AI, Lushnikova EL. Bull Exp Biol Med. 2017 Jun;163(2):280-283. doi: 10.1007/s10517-017-3784-0
Structural Reorganization of the Vaginal Mucosa in Stress Urinary Incontinence under Conditions of Er:YAG Laser Treatment - Read Full Text.
Lapii GA, Yakovleva AY, Neimark AI. Bulletin of Experimental Biology and Medicine, 2017, 162(4):510–514.
* Certain applications discussed in this scientific literature may not yet be cleared by the FDA.
Additional Resources: visit the Laser and Health Academy* website for additional information about medical laser treatments that can be performed with Fotona laser systems.
Testimonials
"At the beginning I didn't believe that such a simple treatment as IncontiLase could be so effective in treating indications such as mild and moderate Stress Urinary Incontinence. But when my first patient, whom I treated one year ago for moderate SUI, reported that she is dry from the day of the procedure, I began to change my mind. Today, after treating many patients, I can say that the results we have obtained with this new technology are exceeding my expectations. And after one year, my first patient is still dry and very happy with the change IncontiLase brought to her life."